Trust Company’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $62.9K | Hold |
291
| – | – | 0.01% | 270 |
|
|
2026
Q1 | $53.3K | Hold |
291
| – | – | 0.01% | 291 |
|
|
2025
Q4 | $51.2K | Buy |
291
+128
| +79% | +$20.9K | ﹤0.01% | 288 |
|
|
2025
Q3 | $22.8K | Hold |
163
| – | – | ﹤0.01% | 272 |
|
|
2025
Q2 | $20.5K | Hold |
163
| – | – | ﹤0.01% | 274 |
|
|
2025
Q1 | $22.3K | Hold |
163
| – | – | ﹤0.01% | 282 |
|
|
2024
Q4 | $24.9K | Hold |
163
| – | – | ﹤0.01% | 269 |
|
|
2024
Q3 | $31.6K | Hold |
163
| – | – | ﹤0.01% | 231 |
|
|
2024
Q2 | $37.8K | Hold |
163
| – | – | ﹤0.01% | 203 |
|
|
2024
Q1 | $35.1K | Hold |
163
| – | – | ﹤0.01% | 209 |
|
|
2023
Q4 | $42.2K | Hold |
163
| – | – | 0.01% | 192 |
|
|
2023
Q3 | $41.9K | Hold |
163
| – | – | 0.01% | 194 |
|
|
2023
Q2 | $46.4K | Hold |
163
| – | – | 0.01% | 193 |
|
|
2023
Q1 | $45.3K | Hold |
163
| – | – | 0.01% | 193 |
|
|
2022
Q4 | $45K | Hold |
163
| – | – | 0.01% | 189 |
|
|
2022
Q3 | $44K | Hold |
163
| – | – | 0.01% | 186 |
|
|
2022
Q2 | $33K | Hold |
163
| – | – | 0.01% | 212 |
|
|
2022
Q1 | $34K | Hold |
163
| – | – | 0.01% | 217 |
|
|
2021
Q4 | $39K | Hold |
163
| – | – | 0.01% | 191 |
|
|
2021
Q3 | $46K | Hold |
163
| – | – | 0.01% | 174 |
|
|
2021
Q2 | $56K | Sell |
163
-37
| -19% | -$11.2K | 0.04% | 161 |
|
|
2021
Q1 | $56K | Buy |
200
+37
| +23% | +$9.98K | 0.04% | 166 |
|
|
2020
Q4 | $40K | Buy |
163
+126
| +341% | +$32.5K | 0.03% | 169 |
|
|
2020
Q3 | $10K | Buy |
+37
| New | +$10.3K | 0.01% | 252 |
|
|
2020
Q2 | – | Sell |
-10
| Closed | -$3K | – | 307 |
|
|
2020
Q1 | $3K | Hold |
10
| – | – | ﹤0.01% | 257 |
|
|
2019
Q4 | $3K | Hold |
10
| – | – | ﹤0.01% | 268 |
|
|
2019
Q3 | $2K | Sell |
10
-43
| -81% | -$10K | ﹤0.01% | 299 |
|
|
2019
Q2 | $12K | Buy |
+53
| New | +$12.2K | 0.01% | 236 |
|
|
2018
Q3 | – | Sell |
-25
| Closed | -$7K | – | 340 |
|
|
2018
Q2 | $7K | Buy |
+25
| New | +$7.03K | ﹤0.01% | 291 |
|
Other funds holding BIIB
Trust Company's BIIB Position: Q2 2026 in Review
Trust Company held its Biogen (BIIB) position steady in Q2 2026 at 291 shares worth $62.9K. The position accounts for 0.01% of the portfolio, ranked #270.
Trust Company first reported a position in BIIB in Q2 2018 and has held it in 29 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Trust Company held 291 shares of Biogen worth $62.9K as of Q2 2026.
- Trust Company left its Biogen share count unchanged in Q2 2026.
- Biogen made up 0.01% of Trust Company's portfolio in Q2 2026, its #270 holding.
- Trust Company first reported a position in Biogen in Q2 2018 and has held it in 29 quarters since.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.